Groupe Bastide Expands Into the North American Respiratory Care Market With the Acquisition of a Canadian Leader
16 Marzo 2022 - 2:09PM
Business Wire
Regulatory News:
Bastide Le Confort Médical (Paris:BLC) (Euronext Paris
Compartment B: BLC, FR0000035370), a specialist in home healthcare services,
announces that it has completed a strategic acquisition in North
America with the purchase of Medpro Respiratory Care, one of the
largest respiratory care operators in Canada. Through this
operation, Groupe Bastide is strengthening its position in a
strategic activity and taking a position in a market with very
strong potential.
Acquisition of one of the major Canadian players in
respiratory care
Groupe Bastide acquired 100% of the capital of Medpro
Respiratory Care (including its subsidiary Healthy Heart SleepCo),
a major respiratory care operator in Canada. Founded in 1998,
Medpro Respiratory Care achieved sales of C$14m in 2020,
approximately €9.5m. The group operates in British Columbia,
Alberta and Ontario. It offers a wide range of respiratory products
and services to meet the needs of its customers, particularly
in:
- Oxygen therapy ;
- Non-invasive ventilation ;
- Sleep apnea.
The market for respiratory care throughout the country is
currently estimated at C$0.9bn. Given the chronic under-diagnosis,
the total addressable market amounts to C$2.4bn and thus offers a
significant margin for growth and conquest throughout Canada. The
level of margin, resulting from the combination of public and
private management, is comparable to or even higher than the
European markets.
Strategic shift to Canada and North America
The Medpro Respiratory Care acquisition is perfectly in line
with Groupe Bastide's strategy and meets three key objectives:
- Continue the Group's internationalization;
- Increase the share of higher value-added businesses, including
respiratory care, in its mix;
- Diversify its pricing risk, with a larger private share than in
France and, as a result, less sensitivity to any price cuts decided
by regional governments.
This transaction also enables Groupe Bastide to build up its
first bridgehead in North America, one of the areas where it plans
to strengthen its position, particularly in respiratory care, in
order to diversify its locations, stakeholders and business models.
Medpro Respiratory Care will be managed by the current founders and
executives.
About Groupe Bastide Le Confort Médical
Created in 1977 by Guy Bastide, the BASTIDE group is a leading
European provider of home healthcare services. Present in 5
countries, BASTIDE develops a permanent quality approach and is
committed to providing medical devices and associated services that
best meet patients’ needs in key health areas: diabetes, nutrition,
perfusion, respiratory, stomatherapy and urology. BASTIDE is listed
on Euronext Paris (ISIN: FR0000035370, Reuters BATD.PA, - Bloomberg
BLC: FP).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220316006004/en/
Groupe Bastide Vincent Bastide Olivier Jourdanney T. +33
(0)4 66 38 68 08
NewCap Investor Relations Emmanuel Huynh T. +33
(0)1 44 71 20 42 bastide@newcap.eu
NewCap Press Relations Nicolas Merigeau T. +33
(0)1 44 71 94 98 bastide@newcap.eu
Bastide Le Confort Medical (EU:BLC)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Bastide Le Confort Medical (EU:BLC)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025